Esophageal metastasis of breast carcinoma
Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer...
Gespeichert in:
Veröffentlicht in: | Breast cancer (Tokyo, Japan) Japan), 2009-04, Vol.16 (2), p.151-156 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 156 |
---|---|
container_issue | 2 |
container_start_page | 151 |
container_title | Breast cancer (Tokyo, Japan) |
container_volume | 16 |
creator | Wada, Yasuo Harada, Nobuko Ohara, Kazuhiro Kawata, Hironori Iwasaki, Hironori Kawamura, Yuuichiro Gomi, Takashi Ohtoshi, Masahiro Nakashima, Yasuaki |
description | Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer. |
doi_str_mv | 10.1007/s12282-008-0068-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67101535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67101535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfZk-AhOkl2k-xRSqtCwYueQzYfdcvupibdg__elC14EzJkhnnnHeZB6JbAIwEQT4lQKikGkDm4xPwMzYmUgEvK2HnOWQmYSy5n6CqlHUDJBPBLNCNScCo5m6OHVQr7L711uit6d9ApvzYVwRdNdLkqjI6mHUKvr9GF111yN6d_gT7Xq4_lK968v7wtnzfYsLo6YFFRW1YAntV5M5dQCk2tEOCN5R7A1dRaVtdCS2o0r11jKDSUGgGy9N6yBbqffPcxfI8uHVTfJuO6Tg8ujElxQYBUrMpCMglNDClF59U-tr2OP4qAOvJREx-V-agjH8XzzN3JfGx6Z_8mTkCygE6ClFvD1kW1C2Mc8sH_uP4CDiZuyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67101535</pqid></control><display><type>article</type><title>Esophageal metastasis of breast carcinoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wada, Yasuo ; Harada, Nobuko ; Ohara, Kazuhiro ; Kawata, Hironori ; Iwasaki, Hironori ; Kawamura, Yuuichiro ; Gomi, Takashi ; Ohtoshi, Masahiro ; Nakashima, Yasuaki</creator><creatorcontrib>Wada, Yasuo ; Harada, Nobuko ; Ohara, Kazuhiro ; Kawata, Hironori ; Iwasaki, Hironori ; Kawamura, Yuuichiro ; Gomi, Takashi ; Ohtoshi, Masahiro ; Nakashima, Yasuaki</creatorcontrib><description>Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/s12282-008-0068-6</identifier><identifier>PMID: 18762863</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Aged ; Antineoplastic Agents, Hormonal - therapeutic use ; Breast Neoplasms - drug therapy ; Breast Neoplasms - pathology ; Breast Neoplasms - radiotherapy ; Cancer Research ; Carcinoma, Ductal, Breast - drug therapy ; Carcinoma, Ductal, Breast - radiotherapy ; Carcinoma, Ductal, Breast - secondary ; Case Report ; Combined Modality Therapy ; Esophageal Neoplasms - drug therapy ; Esophageal Neoplasms - radiotherapy ; Esophageal Neoplasms - secondary ; Female ; Humans ; Medicine ; Medicine & Public Health ; Oncology ; Radiotherapy Dosage ; Surgery ; Surgical Oncology ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>Breast cancer (Tokyo, Japan), 2009-04, Vol.16 (2), p.151-156</ispartof><rights>The Japanese Breast Cancer Society 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</citedby><cites>FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12282-008-0068-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12282-008-0068-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18762863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wada, Yasuo</creatorcontrib><creatorcontrib>Harada, Nobuko</creatorcontrib><creatorcontrib>Ohara, Kazuhiro</creatorcontrib><creatorcontrib>Kawata, Hironori</creatorcontrib><creatorcontrib>Iwasaki, Hironori</creatorcontrib><creatorcontrib>Kawamura, Yuuichiro</creatorcontrib><creatorcontrib>Gomi, Takashi</creatorcontrib><creatorcontrib>Ohtoshi, Masahiro</creatorcontrib><creatorcontrib>Nakashima, Yasuaki</creatorcontrib><title>Esophageal metastasis of breast carcinoma</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><addtitle>Breast Cancer</addtitle><description>Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.</description><subject>Aged</subject><subject>Antineoplastic Agents, Hormonal - therapeutic use</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - radiotherapy</subject><subject>Cancer Research</subject><subject>Carcinoma, Ductal, Breast - drug therapy</subject><subject>Carcinoma, Ductal, Breast - radiotherapy</subject><subject>Carcinoma, Ductal, Breast - secondary</subject><subject>Case Report</subject><subject>Combined Modality Therapy</subject><subject>Esophageal Neoplasms - drug therapy</subject><subject>Esophageal Neoplasms - radiotherapy</subject><subject>Esophageal Neoplasms - secondary</subject><subject>Female</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Radiotherapy Dosage</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_gBfZk-AhOkl2k-xRSqtCwYueQzYfdcvupibdg__elC14EzJkhnnnHeZB6JbAIwEQT4lQKikGkDm4xPwMzYmUgEvK2HnOWQmYSy5n6CqlHUDJBPBLNCNScCo5m6OHVQr7L711uit6d9ApvzYVwRdNdLkqjI6mHUKvr9GF111yN6d_gT7Xq4_lK968v7wtnzfYsLo6YFFRW1YAntV5M5dQCk2tEOCN5R7A1dRaVtdCS2o0r11jKDSUGgGy9N6yBbqffPcxfI8uHVTfJuO6Tg8ujElxQYBUrMpCMglNDClF59U-tr2OP4qAOvJREx-V-agjH8XzzN3JfGx6Z_8mTkCygE6ClFvD1kW1C2Mc8sH_uP4CDiZuyw</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Wada, Yasuo</creator><creator>Harada, Nobuko</creator><creator>Ohara, Kazuhiro</creator><creator>Kawata, Hironori</creator><creator>Iwasaki, Hironori</creator><creator>Kawamura, Yuuichiro</creator><creator>Gomi, Takashi</creator><creator>Ohtoshi, Masahiro</creator><creator>Nakashima, Yasuaki</creator><general>Springer Japan</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090401</creationdate><title>Esophageal metastasis of breast carcinoma</title><author>Wada, Yasuo ; Harada, Nobuko ; Ohara, Kazuhiro ; Kawata, Hironori ; Iwasaki, Hironori ; Kawamura, Yuuichiro ; Gomi, Takashi ; Ohtoshi, Masahiro ; Nakashima, Yasuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-752d4500f3968668047a2d770fcd6f00e92dd3997a82ca69ebc20b22c7084ffd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aged</topic><topic>Antineoplastic Agents, Hormonal - therapeutic use</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - radiotherapy</topic><topic>Cancer Research</topic><topic>Carcinoma, Ductal, Breast - drug therapy</topic><topic>Carcinoma, Ductal, Breast - radiotherapy</topic><topic>Carcinoma, Ductal, Breast - secondary</topic><topic>Case Report</topic><topic>Combined Modality Therapy</topic><topic>Esophageal Neoplasms - drug therapy</topic><topic>Esophageal Neoplasms - radiotherapy</topic><topic>Esophageal Neoplasms - secondary</topic><topic>Female</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Radiotherapy Dosage</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wada, Yasuo</creatorcontrib><creatorcontrib>Harada, Nobuko</creatorcontrib><creatorcontrib>Ohara, Kazuhiro</creatorcontrib><creatorcontrib>Kawata, Hironori</creatorcontrib><creatorcontrib>Iwasaki, Hironori</creatorcontrib><creatorcontrib>Kawamura, Yuuichiro</creatorcontrib><creatorcontrib>Gomi, Takashi</creatorcontrib><creatorcontrib>Ohtoshi, Masahiro</creatorcontrib><creatorcontrib>Nakashima, Yasuaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wada, Yasuo</au><au>Harada, Nobuko</au><au>Ohara, Kazuhiro</au><au>Kawata, Hironori</au><au>Iwasaki, Hironori</au><au>Kawamura, Yuuichiro</au><au>Gomi, Takashi</au><au>Ohtoshi, Masahiro</au><au>Nakashima, Yasuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Esophageal metastasis of breast carcinoma</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><stitle>Breast Cancer</stitle><addtitle>Breast Cancer</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>16</volume><issue>2</issue><spage>151</spage><epage>156</epage><pages>151-156</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Esophageal metastasis from primary breast cancer is an unusual manifestation. We recently treated a patient with dysphagia, whose breast cancer had been treated in the distant past. A 70-year-old woman had been followed regularly in our outpatient clinic for 14 years after her primary breast cancer treatment, with no apparent tumor recurrence. After 2 years absence, she consulted our clinic with progressive dysphagia. Contrast esophagography and endoscopic examination with ultrasonography revealed a protruding submucosal tumor that was histopathologically diagnosed as esophageal metastasis of breast cancer. Radiation therapy involving a total of 60 Gy in combination with aromatase inhibitor was given. The patient’s dysphagia was greatly relieved, concomitant with marked improvement of the stenotic lesion on imaging. Since treatment for recurrent breast cancer is generally palliative, systemic (chemo- and/or endocrine-) therapy in combination with radiotherapy is the first-line option for esophageal metastasis of breast cancer.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>18762863</pmid><doi>10.1007/s12282-008-0068-6</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1340-6868 |
ispartof | Breast cancer (Tokyo, Japan), 2009-04, Vol.16 (2), p.151-156 |
issn | 1340-6868 1880-4233 |
language | eng |
recordid | cdi_proquest_miscellaneous_67101535 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Aged Antineoplastic Agents, Hormonal - therapeutic use Breast Neoplasms - drug therapy Breast Neoplasms - pathology Breast Neoplasms - radiotherapy Cancer Research Carcinoma, Ductal, Breast - drug therapy Carcinoma, Ductal, Breast - radiotherapy Carcinoma, Ductal, Breast - secondary Case Report Combined Modality Therapy Esophageal Neoplasms - drug therapy Esophageal Neoplasms - radiotherapy Esophageal Neoplasms - secondary Female Humans Medicine Medicine & Public Health Oncology Radiotherapy Dosage Surgery Surgical Oncology Tomography, X-Ray Computed Treatment Outcome |
title | Esophageal metastasis of breast carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A10%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Esophageal%20metastasis%20of%20breast%20carcinoma&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Wada,%20Yasuo&rft.date=2009-04-01&rft.volume=16&rft.issue=2&rft.spage=151&rft.epage=156&rft.pages=151-156&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/s12282-008-0068-6&rft_dat=%3Cproquest_cross%3E67101535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67101535&rft_id=info:pmid/18762863&rfr_iscdi=true |